Author(s): Carla Denise Bonan
Date: 2022
Persistent ID: https://hdl.handle.net/10923/22570
Origin: Oasisbr
Subject(s): ectonucleotidases; ectonucleotidases; ectonucleotidases
Author(s): Carla Denise Bonan
Date: 2022
Persistent ID: https://hdl.handle.net/10923/22570
Origin: Oasisbr
Subject(s): ectonucleotidases; ectonucleotidases; ectonucleotidases
Submitted by Biblioteca Suporte PUCRS (biblioteca.suporte@pucrs.br) on 2022-08-15T18:21:36Z No. of bitstreams: 2 Ectonucleotidases_and_NucleotideNucleoside_Transporters_as_Pharmacological_Targets_for_Neurological_Disorders.pdf: 425723 bytes, checksum: a606b56cf571e1509c220e3e4064a139 (MD5) Ectonucleotidases_and_NucleotideNucleoside_Transporters_as_Pharmacological_Targets_for_Neurological_Disorders.pdf: 425723 bytes, checksum: a606b56cf571e1509c220e3e4064a139 (MD5)
Made available in DSpace on 2022-08-15T18:21:36Z (GMT). No. of bitstreams: 2 Ectonucleotidases_and_NucleotideNucleoside_Transporters_as_Pharmacological_Targets_for_Neurological_Disorders.pdf: 425723 bytes, checksum: a606b56cf571e1509c220e3e4064a139 (MD5) Ectonucleotidases_and_NucleotideNucleoside_Transporters_as_Pharmacological_Targets_for_Neurological_Disorders.pdf: 425723 bytes, checksum: a606b56cf571e1509c220e3e4064a139 (MD5) Previous issue date: 2012